C-reactive protein and the insulin-like growth factor (IGF)-system in relation to risk of cardiovascular disease in different ethnic groups (Q44574938)

4 December 2017

C-reactive protein and the insulin-like growth factor (IGF)-system in relation to risk of cardiovascular disease in different ethnic groups (English)

1 reference

4 December 2017

cardiovascular disease

1 reference

2

1 reference

4 December 2017

Adrian H Heald

1

1 reference

4 December 2017

Fiona Ivison

3

1 reference

4 December 2017

Ian Laing

4

1 reference

4 December 2017

J Martin Gibson

5

1 reference

4 December 2017

Kennedy Cruickshank

6

1 reference

4 December 2017

language of work or name

1 reference

1 September 2003

1 reference

4 December 2017

1 reference

4 December 2017

170

1 reference

4 December 2017

79-86

1 reference

4 December 2017

1

1 reference

Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group

4 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900235-1

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900235-1

Prospective study of C-reactive protein in relation to the development of diabetes and metabolic syndrome in the Mexico City Diabetes Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900235-1

C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900235-1

The relation of body fat mass and distribution to markers of chronic inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900235-1

Does recombinant human insulin-like growth factor-1 have a role in the treatment of diabetes?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900235-1

Short-term metabolic effects of recombinant human insulin-like growth factor I in healthy adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900235-1

Liver-specific igf-1 gene deletion leads to muscle insulin insensitivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900235-1

Liver-derived IGF-I is of importance for normal carbohydrate and lipid metabolism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900235-1

Insulin-like growth factor binding proteins: new proteins, new functions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900235-1

Insulin-like growth factor binding protein-1: recent findings and new directions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900235-1

Close relation of fasting insulin-like growth factor binding protein-1 (IGFBP-1) with glucose tolerance and cardiovascular risk in two populations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900235-1

Circulating concentrations of insulin-like growth factor-I and development of glucose intolerance: a prospective observational study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900235-1

A polymorphism in the gene for IGF-I: functional properties and risk for type 2 diabetes and myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900235-1

Epidemiology of the insulin-like growth factor system in three ethnic groups.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900235-1

Stimulation of insulin-like growth factor binding protein-1 synthesis by interleukin-1beta: requirement of the mitogen-activated protein kinase pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900235-1

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900235-1

Comparison of tests of beta-cell function across a range of glucose tolerance from normal to diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900235-1

Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900235-1

Assessment of insulin sensitivity and beta-cell function from measurements in the fasting state and during an oral glucose tolerance test.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900235-1

High prevalence of type 2 diabetes in all ethnic groups, including Europeans, in a British inner city: relative poverty, history, inactivity, or 21st century Europe?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900235-1

Hypertension in four African-origin populations: current 'Rule of Halves', quality of blood pressure control and attributable risk of cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900235-1

Ethnic differences in mortality from cardiovascular disease in the UK: do they persist in people with diabetes?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900235-1

Ethnic differences in fasting plasma C-peptide and insulin in relation to glucose tolerance and blood pressure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900235-1

Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900235-1

A solid-phase enzyme immunoassay for C-reactive protein: clinical value and the effect of rheumatoid factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900235-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900235-1

Measurement of insulin-like growth factor-II in human plasma using a specific monoclonal antibody-based two-site immunoradiometric assay.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900235-1

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900235-1

Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900235-1

C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900235-1

Regulation of the acute phase response by cytokines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900235-1

Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900235-1

Associations of serum C-reactive protein with fasting insulin, glucose, and glycosylated hemoglobin: the Third National Health and Nutrition Examination Survey, 1988-1994.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900235-1

C reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900235-1

Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the Women's Health Initiative observational study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900235-1

The association of c-reactive protein, serum amyloid a and fibrinogen with prevalent coronary heart disease--baseline findings of the PAIS project

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900235-1

Urinary IGF and IGF binding protein-3 in children with disordered growth. The North West Paediatric Endocrine Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900235-1

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0021-9150(03)00235-1

1 reference

release_d3tuwrlsvfg2dghxq4ewnrklcq

4 December 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/d3tuwrlsvfg2dghxq4ewnrklcq

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference